Published in

American Association for the Advancement of Science, Science Translational Medicine, 555(12), 2020

DOI: 10.1126/scitranslmed.abc9396

Links

Tools

Export citation

Search in Google Scholar

An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Journal article published in 2020 by Jesse H. Erasmus ORCID, Amit P. Khandhar ORCID, Megan A. O’Connor ORCID, Alexandra C. Walls, Emily A. Hemann ORCID, Patience Murapa, Jacob Archer, Shanna Leventhal, James T. Fuller ORCID, Thomas B. Lewis, Kevin E. Draves, Samantha Randall, Kathryn A. Guerriero, Malcolm S. Duthie, Darrick Carter ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Replicating RNA vaccine delivered by lipid inorganic nanoparticles induces neutralizing antibody and T cells against SARS-CoV-2 in mice and macaques.